About this supplement
Injection-Related Risks With Injectable GHK-Cu FDA identifies compounded injectable drugs containing GHK-Cu as a potential immunogenicity risk because of aggregation and peptide-related impurities, and FDA notes limited human data to inform safety considerations [8]
Dai Y, Luo J, Xiang E et al (2021) Prenatal exposure to Retrorsine induces developmental toxicity and hepatotoxicity of fetal rats in a sex-dependent manner: the role of pregnane X receptor activation
Compare this to peptides like GHK-Cu or TB-500 , which may require more frequent dosing due to shorter half-lives
A peptide being discussed online, sold by a vendor, or mentioned in early research does not mean it has been approved for a patients injury, pain, gut symptoms, or recovery goals
Certain medications use sublingual delivery specifically to bypass first-pass metabolism in the liver